The use of modern telemedicine technologies in an innovative optimal cardiac rehabilitation program for patients after myocardial revascularization: Concept and design of RESTORE, a randomized clinical trial.


Journal

Cardiology journal
ISSN: 1898-018X
Titre abrégé: Cardiol J
Pays: Poland
ID NLM: 101392712

Informations de publication

Date de publication:
2019
Historique:
received: 25 09 2018
accepted: 08 11 2018
pubmed: 20 12 2018
medline: 29 7 2020
entrez: 20 12 2018
Statut: ppublish

Résumé

Despite proven efficacy of cardiac rehabilitation (CR) in reducing the all-cause mortality in patients after myocardial revascularization, the penetration of CR, due to patient-related factors and referral rates remains limited. To improve the outcomes, home-based tele-rehabilitation (TR) has been proposed recently. In theory TR enhances the effects of standard CR procedures due to implementation of an intelligent monitoring system designed to ensure optimal training through on-demand transmission of vital signs, aimed at motivating the patients through daily schedule reminders, setting daily goals and creating a platform for mutual feedback. Several meta-analyses assessing various studies comparing these two methods (CR and TR) have proven that they are at least equally effective, with some of the research showing superiority of TR. Although there was a small sample size, lack of long-term follow-up, reporting effects of TR itself, no integration with tools designed for coaching, motivating and promoting a healthy lifestyle constitutes an important limitation. The latter carries a hopeful prognosis for improvement when utilizing a broad-spectrum approach, especially with use of dedicated technological solutions exploiting the fact of a large and yet rapidly increasing penetration of smartphones, mobile PCs and tablets in the population. The above-mentioned findings worked as the basis and rationale for commencing the RESTORE project aimed at developing and delivering state-of-the-art, comprehensive TR for patients after myocardial revascularization and evaluating its molecular aspect in view of how it influences the atherosclerosis progression attenuation. This paper presents the current state and rationale behind the project based on up-to-date TR efficacy data.

Identifiants

pubmed: 30566211
pii: VM/OJS/J/60138
doi: 10.5603/CJ.a2018.0157
pmc: PMC8084403
doi:

Types de publication

Clinical Trial Protocol Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

594-603

Références

J Cardiopulm Rehabil Prev. 2015 Nov-Dec;35(6):380-9
pubmed: 26034937
Lancet. 2009 Mar 14;373(9667):929-40
pubmed: 19286092
Int J Cardiol. 2016 Oct 15;221:963-9
pubmed: 27441476
Eur Heart J. 2015 Apr 21;36(16):950-1
pubmed: 25899410
Eur Heart J Qual Care Clin Outcomes. 2018 Jul 1;4(3):168-172
pubmed: 29325067
Eur Heart J. 2003 Jul;24(13):1273-8
pubmed: 12831822
Heart. 2016 Aug 1;102(15):1183-92
pubmed: 26936337
Int J Cardiol. 2015 Jan 20;179:153-9
pubmed: 25464436
Cochrane Database Syst Rev. 2000;(4):CD001800
pubmed: 11034729
Cochrane Database Syst Rev. 2017 Jun 30;6:CD007130
pubmed: 28665511
Kardiol Pol. 2015;73(3):142-58
pubmed: 25371307
Eur J Prev Cardiol. 2016 Dec;23(18):1914-1939
pubmed: 27777324
Eur Heart J Acute Cardiovasc Care. 2015 Dec;4(6):509-17
pubmed: 25301783
Circulation. 2007 Oct 9;116(15):1653-62
pubmed: 17893274
J Telemed Telecare. 2015 Jan;21(1):45-53
pubmed: 25475219
Eur J Prev Cardiol. 2015 Aug;22(8):959-71
pubmed: 25488550
Int J Rehabil Res. 2005 Sep;28(3):251-7
pubmed: 16046919
J Am Coll Cardiol. 2015 Jun 23;65(24):2652-2659
pubmed: 26088305
Open Heart. 2016 Sep 14;3(2):e000463
pubmed: 27738516
Prog Cardiovasc Dis. 2014 Mar-Apr;56(5):522-9
pubmed: 24607017
J Am Coll Cardiol. 2008 Apr 29;51(17):1619-31
pubmed: 18436113
J Am Coll Cardiol. 2009 Jun 30;54(1):25-33
pubmed: 19555836
Circulation. 1989 Aug;80(2):234-44
pubmed: 2665973
Rev Esp Cardiol (Engl Ed). 2016 Oct;69(10):939
pubmed: 27692125
Phys Ther. 2015 Feb;95(2):167-79
pubmed: 25278337

Auteurs

Krzysztof Milewski (K)

Center for Cardiovascular Research and Development, American Heart of Poland, Katowice, Poland, Poland. k.milewski@ahp-ccrd.org.
The Jerzy Kukuczka Academy of Physical Education, Katowice, Poland. k.milewski@ahp-ccrd.org.

Andrzej Małecki (A)

The Jerzy Kukuczka Academy of Physical Education, Katowice, Poland.

Dominika Orszulik-Baron (D)

Center for Cardiovascular Research and Development, American Heart of Poland, Katowice, Poland, Poland.

Mateusz Kachel (M)

Center for Cardiovascular Research and Development, American Heart of Poland, Katowice, Poland, Poland.

Piotr Hirnle (P)

Center for Cardiovascular Research and Development, American Heart of Poland, Katowice, Poland, Poland.

Marek Orczyk (M)

Center for Cardiovascular Research and Development, American Heart of Poland, Katowice, Poland, Poland.
The Jerzy Kukuczka Academy of Physical Education, Katowice, Poland.

Rafał Dunal (R)

Silvermedia, Krakow, Poland.

Grzegorz Mikołajowski (G)

The Jerzy Kukuczka Academy of Physical Education, Katowice, Poland.

Adam Janas (A)

Center for Cardiovascular Research and Development, American Heart of Poland, Katowice, Poland, Poland.

Zbigniew Nowak (Z)

The Jerzy Kukuczka Academy of Physical Education, Katowice, Poland.

Karol Kozak (K)

Universitätsklinikum Carl Gustav Carus Dresden.

Wojciech Roskiewicz (W)

Fraunhofer-Gesellschaft zur Förderung der Angewandten Forschung e.V., München, Germany.

Katarzyna Nierwińska (K)

The Jerzy Kukuczka Academy of Physical Education, Katowice, Poland.

Andrzej Izworski (A)

AGH University of Science and Technology, Krakow, Poland.

Adam Rybicki (A)

Uzdrowisko Ustron Health Resort, Poland.

Piotr P Buszman (PP)

Center for Cardiovascular Research and Development, American Heart of Poland, Katowice, Poland, Poland.
Andrzej Frycz Modrzewski Krakow University, Faculty of Medicine and Health Sciences, Krakow, Poland.

Ryszard Piotrowicz (R)

Head of Department of Cardiac Rehabilitation and Noninvasive Electrocardiology, National Institute of Cardiology, Warsaw, Poland.

Pawel E Buszman (PE)

Center for Cardiovascular Research and Development, American Heart of Poland, Katowice, Poland, Poland.
Andrzej Frycz Modrzewski Krakow University, Faculty of Medicine and Health Sciences, Krakow, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH